<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template"><id>896a0c0d-bb5b-4d6a-b628-ed3cfcb08cab</id><name>Anti_Infective Agents Sepsis Peds Order Group</name><description><lifecycle_state>Initial</lifecycle_state><details><purpose/><use/><misuse/></details><other_details><item><key>MetaDataSet:Sample Set </key><value>Template metadata sample set </value></item><item><key>Acknowledgements</key><value/></item><item><key>Business Process Level</key><value/></item><item><key>Care setting</key><value/></item><item><key>Client group</key><value/></item><item><key>Clinical Record Element</key><value/></item><item><key>Copyright</key><value/></item><item><key>Issues</key><value/></item><item><key>Owner</key><value/></item><item><key>Sign off</key><value/></item><item><key>Speciality</key><value/></item><item><key>User roles</key><value/></item></other_details></description><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]"><items><item><key>CKT.Clinical Guidance</key><value>&lt;p&gt;High risk for Severe Sepsis in patients:&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;Less than 56 days of age&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;With a Central line&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;Immunocompromised (BMT, solid organ transplant, malignancy, asplenia)&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;With Sickle cell disease&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;With Pre-existing neurologic dysfunction that limits mental status evaluation (conditions that alter levels of consciousness)&lt;br&gt;&amp;nbsp;&lt;br&gt;Antibiotic choices should be tailored to suspected site of infection. Drug doses listed are taken from Lexicomp: Pediatric Drug Information.&lt;br&gt;&amp;nbsp;&lt;br&gt;Consider consulting Infectious Disease if:&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;Patient with a severe beta-lactam allergy/ anaphylaxis&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;Multi-drug resistant organism suspected&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;MRSA colonization&lt;br&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;Severe sepsis&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]"><items><item><key>Transform.Technical Notes</key><value>&lt;p&gt;Restricted to&amp;nbsp;age 0 to 28 days&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]"><items><item><key>CKT.Clinical Guidance</key><value>&lt;p&gt;Consider empiric treatment for Neonatal Sepsis with Ampicillin AND either Cefotaxime OR Gentamicin. Cefotaxime preferred in patients at high risk of acute kidney injury.&lt;br&gt;&amp;nbsp;&lt;br&gt;Higher doses are required for suspected meningitis. CefTRIAXone is not recommended in neonates less than 44 weeks CGA, if hyperbilirubinemia or if receiving calcium-containing intravenous solutions.&lt;br&gt;&amp;nbsp;&lt;br&gt;Anaerobic coverage is required if there is an intra-abdominal source. &amp;nbsp;Vancomycin is indicated if MRSA infection. &amp;nbsp;Tailor antibiotics according to presentation.&lt;br&gt;&amp;nbsp;&lt;br&gt;Acyclovir should be given with ampicillin and either cefotaxime or gentamicin for patients with clinical presentation consistent with herpes simplex infection.&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Non-meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;cefoTAXime IV&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Non-meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;gentamicin IV&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]"><items><item><key>CKT.Clinical Guidance</key><value>&lt;p&gt;If less than or equal to 7 days of age, recommended dose: 4-5 mg/kg/dose&lt;/p&gt;&lt;p&gt;If greater than 8 days of age, recommended dose: 4-6 mg/kg/dose&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Non-meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;gentamicin IV&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Non-meningitic dosing, Neonates&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ampicillin IV&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;cefoTAXime IV&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]"><items><item><key>CKT.Clinical Guidance</key><value>&lt;p&gt;If MRSA suspected&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Neonates&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Neonates&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;TERM NEONATES; age 0 to 28 days&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS: Age 29 days to less than 3 months&apos;]"><items><item><key>Transform.Technical Notes</key><value>&lt;p&gt;Restricted to&amp;nbsp;Age 29 days to less than 3 months&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS: Age 29 days to less than 3 months&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]"><items><item><key>CKT.Clinical Guidance</key><value>&lt;p&gt;Consider empiric treatment with CefTRIAXone and Vancomycin in infants with Septic Shock. &amp;nbsp;An alternate regimen of CefTRIAXone +/- Ampicillin could be considered if low suspicion of meningitis or severe sepsis. &amp;nbsp;Anaerobic coverage is required for an intra-abdominal source. &amp;nbsp;Consider Vancomycin for sepsis caused by MRSA. &amp;nbsp;Tailor antibiotics according to clinical presentation.&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS: Age 29 days to less than 3 months&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Non-meningitic dosing, Infants&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS: Age 29 days to less than 3 months&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Infants&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS: Age 29 days to less than 3 months&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]"><items><item><key>Transform.Technical Notes</key><value>&lt;p&gt;Restricted to&amp;nbsp;greater than 3 months and Children&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]"><items><item><key>CKT.Clinical Guidance</key><value>&lt;p&gt;Consider empiric treatment with CefTRIAXone and Vancomycin in older infants and children with Septic Shock. &amp;nbsp;Anaerobic coverage is required for an intra-abdominal source. &amp;nbsp;Consider Vancomycin for sepsis caused by MRSA. &amp;nbsp;Tailor antibiotics according to clinical presentation.&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Non-meningitic dosing, Children&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Children&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Acyclovir (children less than 12 years of age - recommended dose 10-15 mg/kg/dose)&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;Y&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Children&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Acyclovir (children less than 12 years of age - recommended dose 10-15 mg/kg/dose)&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Meningitic dosing, Children&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;INFANTS greater than 3 months and Children:&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]"><items><item><key>Transform.Preselected</key><value>&lt;p&gt;N&lt;/p&gt;</value></item></items></annotations><annotations path="[openEHR-EHR-SECTION.adhoc.v1]"><items><item><key>Technical.ﻩ Technical Traceability</key><value>{~AHSID~896a0c0d-bb5b-4d6a-b628-ed3cfcb08cab~NAME~Anti_Infective Agents Sepsis Peds Order Group}</value></item></items></annotations><definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Anti-Infective Agents"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="TERM NEONATES; age 0 to 28 days"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Non-meningitic dosing, Neonates"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 50 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="cefoTAXime IV"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97b2a433-ba9d-4e93-8861-492c3224dc1c" concept_name="PHARM cefoTAXime injection Order" max="1" path="/items" name="cefoTAXime injection; less than or equal to 7 days of age; 50 mg/kg/day, intravenous, every 12 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97b2a433-ba9d-4e93-8861-492c3224dc1c" concept_name="PHARM cefoTAXime injection Order" max="1" path="/items" name="cefoTAXime injection; 8-28 days of age; 50 mg/kg/day, intravenous, every 8 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="gentamicin IV"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c64035f-72ac-454d-bf7b-60d73c421c66" concept_name="PHARM gentamicin injection Order" max="1" path="/items" name="gentamicin conventional dosing; *** mg/kg/day, intravenous, every 24 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d927008-443f-41a9-8b4a-9c7c0ed954be" concept_name="PHARM acyclovir injection Order" max="1" path="/items" name="acyclovir IV; 20 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Meningitic dosing, Neonates"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="ampicillin IV"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; less than or equal to 7 days of age; 300 mg/kg/day, intravenous, every 8 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; greater than 8 days of age; 300 mg/kg/day, intravenous, every 6 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="cefoTAXime IV"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97b2a433-ba9d-4e93-8861-492c3224dc1c" concept_name="PHARM cefoTAXime injection Order" max="1" path="/items" name="cefoTAXime injection; less than or equal to 7 days of age; 150 mg/kg/day, intravenous, every 8 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97b2a433-ba9d-4e93-8861-492c3224dc1c" concept_name="PHARM cefoTAXime injection Order" max="1" path="/items" name="cefoTAXime injection; greater than 8 days of age; 200 mg/kg/day, intravenous, every 6 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="vancomycin IV"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin IV; less than or equal to 7 days of age; 15 mg/kg/dose, intravenous, every 12 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin IV; greater than 8 days of age; 15 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3883821f-01ac-409a-a43d-c581f89f6927" concept_name="LAB Vancomycin Level, Pre-Dose Order" max="1" path="/items" name="Vancomycin Level, Pre-Dose; Pre 3rd dose"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3883821f-01ac-409a-a43d-c581f89f6927" concept_name="LAB Vancomycin Level, Pre-Dose Order" max="1" path="/items" name="Vancomycin Level, Pre-Dose; Pre 5th dose"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3904f72b-698d-4c85-9c5e-b17cac188d47" concept_name="LAB Urea Order" max="1" path="/items" name="Urea; Timed, Pre 3rd dose of vancomycin"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3904f72b-698d-4c85-9c5e-b17cac188d47" concept_name="LAB Urea Order" max="1" path="/items" name="Urea; Timed, Pre 5th dose of vancomycin"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ff3fbde8-2635-4dcd-9b7b-e3e3db07514b" concept_name="LAB Creatinine Order" max="1" path="/items" name="Creatinine; Timed, Pre 3rd dose of vancomycin"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ff3fbde8-2635-4dcd-9b7b-e3e3db07514b" concept_name="LAB Creatinine Order" max="1" path="/items" name="Creatinine; Timed, Pre 5th dose of vancomycin"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d927008-443f-41a9-8b4a-9c7c0ed954be" concept_name="PHARM acyclovir injection Order" max="1" path="/items" name="acyclovir IV; 20 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="INFANTS: Age 29 days to less than 3 months"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Non-meningitic dosing, Infants"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 200 mg/kg/day, intravenous, every 6 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 50 mg/kg/dose, intravenous, every 24 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin IV; 60 mg/kg/day, intravenous, every 6 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d927008-443f-41a9-8b4a-9c7c0ed954be" concept_name="PHARM acyclovir injection Order" max="1" path="/items" name="acyclovir IV; 20 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Meningitic dosing, Infants"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 400 mg/kg/day, intravenous, every 4 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 100 mg/kg/day, intravenous, every 12 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="53b7cae9-0b63-4246-8df3-5785d08fd166" concept_name="vancomycin IV Sepsis Peds Order Group" max="1" path="/items" name="vancomycin IV"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d927008-443f-41a9-8b4a-9c7c0ed954be" concept_name="PHARM acyclovir injection Order" max="1" path="/items" name="acyclovir IV; 20 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="8e5489ac-24bf-449b-8b82-2ab0f6432723" concept_name="Steroids Sepsis Peds Order Group" max="1" path="/items" name="Steroids"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="INFANTS greater than 3 months and Children:"><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Non-meningitic dosing, Children"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 200 mg/kg/day, intravenous, every 6 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 75 mg/kg/day, intravenous, every 24 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin IV; 60 mg/kg/day, intravenous, every 6 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Meningitic dosing, Children"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 400 mg/kg/day, intravenous, every 4 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 100 mg/kg/day, intravenous, every 12 hours, scheduled"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="53b7cae9-0b63-4246-8df3-5785d08fd166" concept_name="vancomycin IV Sepsis Peds Order Group" max="1" path="/items" name="vancomycin IV"/><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Acyclovir (children less than 12 years of age - recommended dose 10-15 mg/kg/dose)"><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d927008-443f-41a9-8b4a-9c7c0ed954be" concept_name="PHARM acyclovir injection Order" max="1" path="/items" name="acyclovir IV; 15 mg/kg/dose, intravenous, every 8 hours, scheduled"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="8e5489ac-24bf-449b-8b82-2ab0f6432723" concept_name="Steroids Sepsis Peds Order Group" max="1" path="/items" name="Steroids"/><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></Item><Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/></definition><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.datetimeorderquestion.v1"><digest id="MD5-CAM-1.0.1">37AE50193A7EA542A4F219FF051EE95B</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1"><digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1"><digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1"><digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1"><digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1"><digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1"><digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest></integrity_checks></template>
